Cryopreservation of human colorectal carcinomas prior to xenografting.
about
Patient-derived tumour xenografts as models for oncology drug developmentPatient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewEstablishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomasThe "North German Tumor Bank of Colorectal Cancer": status report after the first 2 years of support by the German Cancer Aid Foundation.Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis.Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG.Biological and molecular effects of small molecule kinase inhibitors on low-passage human colorectal cancer cell lines.Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.Single nucleotide polymorphism array analysis of microsatellite-stable, diploid/near-diploid colorectal carcinomas without the CpG island methylator phenotype.Establishment and characterization of cell lines from chromosomal instable colorectal cancer.Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.Impacts of a biobank: Bridging the gap in translational cancer medicine."Universal" vitrification of cells by ultra-fast cooling.Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methodsTumor-infiltrating B cells come into vogueEstablishment and characterization of HROC69 - a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft.Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft ModelsOptimized creation of glioblastoma patient derived xenografts for use in preclinical studies.Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.Expression of DIAPH1 is up-regulated in colorectal cancer and its down-regulation strongly reduces the metastatic capacity of colon carcinoma cells.Microdensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in 'biomarker pathology'.Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironmentFrameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome.Patient-derived xenografts as preclinical neuroblastoma models.Colon cancers carrying BRAF V600E and β-catenin T41A activating mutations are resistant to numerous common anticancer drugs.Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer.Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant typeAssessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate
P2860
Q24604068-B856EF97-DD79-4C1E-BF04-BACA0DB73F24Q26741651-0E3B31A0-FD2C-4D0B-ADCE-B2C6A9307B4AQ28484668-213F7821-6566-4ED8-8DF2-8ECAF25929FAQ33455312-3B96C60E-E79D-4879-A305-E42CFD4FA810Q34101011-CEDE4EF7-84F0-4E2F-B2D5-9E068000E101Q34185964-0290CB26-9E0B-4DB3-B41B-521DB982F0EDQ34278085-3DFDE281-8BB2-4CC8-AFC4-53BBB18925AEQ34438553-76ADBBA6-DB54-4592-BF20-1D1CB5D6D281Q34518818-17A1811D-5F83-4E23-8D98-62E260CC993EQ34827208-73DE7FCD-83EE-41CA-93D5-8ADDA8619A64Q34948627-0F709572-57DC-4246-9774-7D7B60C8F6A7Q35119526-82B785C3-3F01-42CF-8451-3F1CBCC8575BQ35188871-28951E88-DDBC-4E5A-B995-2047D5ED206FQ35500444-506F6F31-5C4E-4044-B23D-9D93637E22F4Q36123789-EEDF753C-7E8D-455F-9C13-71647DBA1CCFQ36525540-B2352380-6B57-483F-945D-8132E2E93615Q36806403-D7767C73-E30F-4EF6-89FF-ED058A92ADF0Q37479229-F45D9646-EA20-4E53-A620-FB97B1D109C1Q37635313-51C5FA6E-4EBD-4C71-AC87-4D898935D280Q38722377-924D0E9A-8151-4EC4-8C17-1B9437F57425Q39084391-68A53027-7AF2-4962-9FF1-8F933480A4C5Q39258136-66D9E604-B0C5-4C79-8C53-7BB93741280FQ41561293-B83A35FE-5904-4A45-94CF-41B4540D160EQ42685435-00308298-CE14-459E-AF19-2325D836FD0BQ48218618-5255C059-7720-4B27-A153-644A940E4E01Q50027944-280348C0-8192-4FCA-98AE-51CFF41EAA76Q52655145-BAF27B6F-1B56-4AEF-AC51-F73286DB8346Q54974071-5832A929-D7BD-47EA-AA2E-1D9D8C0C7D14Q57091941-BD12EA23-E72F-4B45-9A4B-BD205D4499EBQ58617824-376C67D8-BF4B-498A-B266-39A26D40891D
P2860
Cryopreservation of human colorectal carcinomas prior to xenografting.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cryopreservation of human colorectal carcinomas prior to xenografting.
@ast
Cryopreservation of human colorectal carcinomas prior to xenografting.
@en
type
label
Cryopreservation of human colorectal carcinomas prior to xenografting.
@ast
Cryopreservation of human colorectal carcinomas prior to xenografting.
@en
prefLabel
Cryopreservation of human colorectal carcinomas prior to xenografting.
@ast
Cryopreservation of human colorectal carcinomas prior to xenografting.
@en
P2093
P2860
P356
P1433
P1476
Cryopreservation of human colorectal carcinomas prior to xenografting.
@en
P2093
Christiane Ostwald
Claudia Maletzki
Ernst Klar
Friedrich Prall
Mathias Krohn
Ulrike Klier
P2860
P2888
P356
10.1186/1471-2407-10-362
P407
P577
2010-07-08T00:00:00Z
P5875
P6179
1004470809